Merck Serono To Establish Major R&D Hub

Merck Serono has become the latest multinational to establish a major research and development (R&D) facility in China. The Geneva-headquartered firm will leverage the country's low-cost base and recruit from a large pool of scientific talent. Following this development, BMI notes that almost all large pharmaceutical companies have similar facilities in China. The exceptions are either niche or conservative players, of which US-based Amgen and Japan's Takeda are respective

To read the full article, please choose one of the following options: